SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061108
Filing Date
2023-11-08
Accepted
2023-11-08 16:10:31
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eq-20230930.htm   iXBRL 10-Q 2595681
2 EX-31.1 eq-ex31_1.htm EX-31.1 15019
3 EX-31.2 eq-ex31_2.htm EX-31.2 15168
4 EX-32.1 eq-ex32_1.htm EX-32.1 10817
  Complete submission text file 0000950170-23-061108.txt   8529669

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eq-20230930_def.xml EX-101.DEF 225732
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eq-20230930_pre.xml EX-101.PRE 341086
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eq-20230930.xsd EX-101.SCH 53283
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eq-20230930_lab.xml EX-101.LAB 465804
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eq-20230930_cal.xml EX-101.CAL 54513
58 EXTRACTED XBRL INSTANCE DOCUMENT eq-20230930_htm.xml XML 1315374
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 231387931
SIC: 2834 Pharmaceutical Preparations